Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway.
- Author:
Sai ZHANG
1
;
Yun-Na TIAN
1
;
Zheng-Yang SONG
1
;
Xiao-Ting WANG
1
;
Xin-Yu WANG
1
;
Jun-Peng XU
1
;
Lin-Bo YUAN
1
;
Wan-Tie WANG
2
Author Information
1. Institute of Ischemia/Reperfusion Injury Research, Wenzhou Medical University, Wenzhou 325035, China.
2. Institute of Ischemia/Reperfusion Injury Research, Wenzhou Medical University, Wenzhou 325035, China. wwt@wmu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Animals;
Male;
Rats;
Caspase 3/metabolism*;
Collagen;
Disease Models, Animal;
Hypertension, Pulmonary/drug therapy*;
Monocrotaline/adverse effects*;
Panax notoginseng/chemistry*;
Proliferating Cell Nuclear Antigen/pharmacology*;
Pulmonary Arterial Hypertension;
Pulmonary Artery/metabolism*;
Rats, Sprague-Dawley;
Receptor, Notch3/genetics*;
RNA, Messenger;
Saline Solution;
Signal Transduction;
Saponins/pharmacology*
- From:
Acta Physiologica Sinica
2023;75(4):503-511
- CountryChina
- Language:Chinese
-
Abstract:
In this study, we investigated the effects of Panax notoginseng saponins (PNS) on pulmonary vascular remodeling and ADAM10/Notch3 pathway in pulmonary arterial hypertension (PAH). PAH rat model was established, and male Sprague Dawley (SD) rats were randomly divided into control group, monocrotaline (MCT) group and MCT+PNS group, with 10 rats in each group. Rats in the control group were intraperitoneally injected with equal volume of normal saline. Rats in the MCT group was injected intraperitoneally with 60 mg/kg MCT on the first day, and then with the same volume of normal saline every day. Rats in the MCT+PNS group was injected intraperitoneally with 60 mg/kg MCT on the first day, and then with 50 mg/kg PNS every day. The modeling time of each group lasted for 21 days. After the model was established, the mean pulmonary artery pressure (mPAP) was measured by right heart catheterization technique, the right ventricular hypertrophy index (RVHI) was calculated, the microscopic morphology and changes of pulmonary vascular wall were observed by HE and Masson staining, and the expressions of ADAM10, Notch3, Hes-1, P27, PCNA, Caspase-3 proteins and mRNA in pulmonary vascular tissue of rats were detected by Western blot and qPCR. The expression and localization of Notch3 and α-SMA were detected by immunofluorescence staining. The protein expression of ADAM10 was detected by immunohistochemical staining. The results showed that compared with the control group, mPAP, RVHI, pulmonary vessels and collagen fibers in the MCT group were significantly increased, the expressions of ADAM10, Notch3, Hes-1, and PCNA protein and mRNA were significantly increased, while the expressions of P27 and Caspase-3 protein and mRNA were decreased significantly. Compared with the MCT group, mPAP and RVHI were significantly decreased, pulmonary vessels were significantly improved and collagen fibers were significantly reduced, the expressions of protein and mRNA of ADAM10, Notch3, Hes-1, and PCNA were decreased in MCT+PNS group, but the expressions of protein and mRNA of P27 and Caspase-3 were increased slightly. The results of immunofluorescence showed that Notch3 and α-SMA staining could overlap, which proved that Notch3 was expressed in smooth muscle cells. The expression of Notch3 in the MCT group was increased significantly compared with that in the control group, while PNS intervention decreased the expression of Notch3. Immunohistochemical staining showed that compared with the control group, the amount of ADAM10 in the MCT group was increased significantly, and the expression of ADAM10 in the MCT+PNS group was decreased compared with the MCT group. These results indicate that PNS can improve the PAH induced by MCT in rats by inhibiting ADAM10/Notch3 signaling pathway.
